GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GenMark Diagnostics Inc (NAS:GNMK) » Definitions » Price-to-Tangible-Book

GenMark Diagnostics (GenMark Diagnostics) Price-to-Tangible-Book : 18.54 (As of Apr. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is GenMark Diagnostics Price-to-Tangible-Book?

As of today (2024-04-26), GenMark Diagnostics's share price is $24.04. GenMark Diagnostics's Tangible Book per Share of Dec. 2020 for the quarter that ended in Dec. 2020 was $1.30. Hence, GenMark Diagnostics's Price to Tangible Book Ratio of today is 18.54.

The historical rank and industry rank for GenMark Diagnostics's Price-to-Tangible-Book or its related term are showing as below:

GNMK' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 8.95   Med: 11.23   Max: 37.3
Current: 18.49

During the past 13 years, GenMark Diagnostics's highest Price to Tangible Book Ratio was 37.30. The lowest was 8.95. And the median was 11.23.

GNMK's Price-to-Tangible-Book is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.67 vs GNMK: 18.49

A closely related ratio is called PB Ratio. As of today, GenMark Diagnostics's share price is $24.04. GenMark Diagnostics's Book Value per Sharefor the quarter that ended in Dec. 2020 was $1.31. Hence, GenMark Diagnostics's P/B Ratio of today is 18.37.


GenMark Diagnostics Price-to-Tangible-Book Historical Data

The historical data trend for GenMark Diagnostics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GenMark Diagnostics Price-to-Tangible-Book Chart

GenMark Diagnostics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.06 3.35 8.66 27.02 11.26

GenMark Diagnostics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.02 21.57 11.67 10.89 11.26

Competitive Comparison of GenMark Diagnostics's Price-to-Tangible-Book

For the Medical Devices subindustry, GenMark Diagnostics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GenMark Diagnostics's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GenMark Diagnostics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where GenMark Diagnostics's Price-to-Tangible-Book falls into.



GenMark Diagnostics Price-to-Tangible-Book Calculation

GenMark Diagnostics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2020 )
=24.04/1.297
=18.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


GenMark Diagnostics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of GenMark Diagnostics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


GenMark Diagnostics (GenMark Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
5964 La Place Court, Carlsbad, CA, USA, 92008-8829
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its operations and assets are in the United States of America.
Executives
Tyler Jensen officer: SVP, Engineering and Tech Dev 5964 LA PLACE COURT CARLSBAD CA 92008
Christine Shaw officer: VP, Assay Development 5964 LA PLACE COURT CARLSBAD CA 92008
Alan Baer Maderazo officer: VP, Qual, Reg, & Clin Affairs 5964 LA PLACE COURT CARLSBAD CA 92008
Michael Gleeson officer: SVP, Corp. Accounts 5964 LA PLACE COURT, SUITE 100 CARLSBAD CA 92008
Sarah Hollis Winkler officer: VP, Human Resources 5964 LA PLACE COURT CARLSBAD CA 92008
Michael John Harkins officer: SVP, Sales 5964 LA PLACE COURT CARLSBAD CA 92008
John Frederick Ek officer: Chief Financial Officer 5964 LA PLACE COURT, CARLSBAD CA 92008
Scott Mendel director, officer: President & CEO 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Eric Stier officer: SVP & General Counsel 5964 LA PLACE COURT CARLSBAD CA 92008
Brian Andrew Mitchell officer: SVP, Operations 5964 LA PLACE COURT CARLSBAD CA 92008
Daryl Faulkner director 5964 LA PLACE COURT, CARLSBAD CA 92008
Michael Kagnoff director DLA PIPER LLP (US) 4365 EXECUTIVE DRIVE, SUITE 1100 SAN DIEGO CA 92121
Lisa M. Giles director DURATA THERAPEUTICS, INC., 200 SOUTH WACKER DRIVE SUITE 2550, CHICAGO IL 60606
Kevin C Oboyle director 5964 LA PLACE COURT, CARLSBAD CA 92008
James Fox director 5964 LA PLACE COURT, CARLSBAD CA 92008